Evidence map›Paper›PMID 27131800›Full record

ArticleAddictive behaviors2016

Neurocognitive, psychiatric, and substance use characteristics in opioid dependent adults.

Franchesca Arias, Julia H Arnsten, Chinazo O Cunningham, Kelly Coulehan, Abigail Batchelder, Mia Brisbane, Katie Segal, Monica Rivera-Mindt

Open access · greenAbstract read
In one paragraph

Article in Addictive behaviors, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Differential expression ofDrug and alcohol dependence reports · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2020
    Article
  20. The Opioid-Addicted Tetrapartite Synapse.Biological psychiatry · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Franchesca AriasPsychology Department, Fordham University, United States. Electronic address: farias2@fordham.edu.
Julia H ArnstenDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, and Montefiore Medical Center, United States.
Chinazo O CunninghamDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, and Montefiore Medical Center, United States.
Kelly CoulehanPsychology Department, Fordham University, United States.
Abigail BatchelderDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, and Montefiore Medical Center, United States.
Mia BrisbaneDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, and Montefiore Medical Center, United States.
Katie SegalDivision of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, and Montefiore Medical Center, United States.
Monica Rivera-MindtPsychology Department, Fordham University, United States; Mount Sinai School of Medicine, Departments of Neurology and Psychiatry, United States.
Albert Einstein College of Medicine · USFordham University · USMontefiore Medical Center · USIcahn School of Medicine at Mount Sinai · US

Funding

Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
Neurocognitive Effects of Opiate Agonist Treatment in HIV Infected Drug UsersR01DA032552 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ARNSTEN, JULIA H., RIVERA-MINDT, MONICA G. · 2012 to 2016
$3.3M
Proteomics CoreP20DA026149 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI FISER, ANDRAS · 2009 to 2011
$2.9M
HIV and Substance Abuse Clinical Addiction Research and Education (CARE) ProgramR25DA023021 · NIDA · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI ARNSTEN, JULIA H. · 2007 to 2014
$2.7M
Medication Adherence Among HIV+ HispanicsK23MH079718 · NIMH · FORDHAM UNIVERSITY · PI RIVERA-MINDT, MONICA G. · 2007 to 2011
$930k
NIAID NIH HHS P30 AI051519NIDA NIH HHS P20 DA026149NIDA NIH HHS R01 DA032552NIDA NIH HHS R25 DA023021NIMH NIH HHS K23 MH079718
6 · The paper itself

Abstract

aimsTo describe neurocognitive function among opioid-dependent adults seeking buprenorphine treatment and to explore the impact of lifetime psychiatric conditions on neurocognitive function. To explore the additive interaction of patient-based characteristics that may help to inform treatment.

designCross-sectional assessment of neurocognitive function, substance use, and psychiatric characteristics of adults seeking buprenorphine treatment within substance use treatment centers in New York City.

participantsThirty-eight opioid-dependent adults seeking buprenorphine treatment. MEASUREMENTS: A comprehensive battery, which included measures of executive functioning, learning, memory, verbal fluency, attention, processing speed, and motor functioning were administered. The Wide Range Achievement Test-Third Edition, the Composite International Diagnostic Interview, and an audio computer assisted structured interview were also completed. Correlations and independent sample t-tests were used to ascertain group differences.

findingsThirty-nine percent of participants were impaired in global neurocognitive function (n=15). Over one third were impaired in either: learning (n=28), memory (n=26), executive functioning (n=17), motor functioning (n=17), attention/working memory (n=14) or verbal fluency (n=12). Lifetime history of alcohol dependence was associated with impairment in global neurocognitive, executive functioning, and motor functioning. Lifetime history of cocaine dependence was associated with impairment in executive functioning and motor functioning (all p's<0.05). Major depressive disorder history was not associated with neurocognitive impairment.

conclusionsAmong this sample of opioid-dependent adults, there were high rates of global and domain-specific neurocognitive impairment, with severe impairment in learning and memory. Lifetime alcohol and cocaine dependence were associated with greater neurocognitive impairment, particularly in executive functioning. Because executive functioning is critical for decision-making and learning/memory dysfunction may interfere with information encoding, these findings suggest that opioid-dependent adults may require enhanced support for medical decision-making.

Indexed as

BuprenorphineCognition DisordersComorbidityCross-Sectional StudiesFemaleHumansMaleMiddle AgedNarcotic AntagonistsNeuropsychological TestsNew York CityOpiate Substitution TreatmentOpioid-Related DisordersBuprenorphineNarcotic AntagonistsBuprenorphine treatmentDepressionNeurocognitive performanceOpioid dependenceSubstance use disorders

Identifiers

PMID27131800
PMCPMC6508857
OpenAlexW2328999128

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.